Nuvation Bio Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nuvation Bio Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Nuvation Bio Inc. Return On Equity for the quarter ending September 30, 2024 was -199 %, a 1422% decline year-over-year.
  • Nuvation Bio Inc. annual Return On Equity for 2023 was -83.6 %, a 450% decline from 2022.
  • Nuvation Bio Inc. annual Return On Equity for 2022 was -15.2 %, a 36.3% decline from 2021.
  • Nuvation Bio Inc. annual Return On Equity for 2021 was -11.2 %, a 65.2% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -199 -186 -1422% Jul 1, 2024 Sep 30, 2024
Q2 2024 -184 -171 -1221% Apr 1, 2024 Jun 30, 2024
Q1 2024 -84.1 -68.3 -434% Jan 1, 2024 Mar 31, 2024
Q4 2023 -83.6 -68.4 -450% Oct 1, 2023 Dec 31, 2023
Q3 2023 -13.1 +2.24 +14.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -14 +0.12 +0.85% Apr 1, 2023 Jun 30, 2023
Q1 2023 -15.8 -4.16 -35.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -15.2 -4.05 -36.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -15.3 -3.7 -31.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -14.1 -0.62 -4.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -11.6 +5.94 +33.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -11.2 +20.9 +65.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -11.6 Jul 1, 2021 Sep 30, 2021
Q2 2021 -13.5 Apr 1, 2021 Jun 30, 2021
Q1 2021 -17.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 -32.1 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.